Intravenous fosaprepitant for the prevention of chemotherapy-induced vomiting in children: A double-blind, placebo-controlled, phase III randomized trial.

Venkatraman RadhakrishnanArchit JoshiJaikumar Govindaswamy RamamoorthySwaminathan RajaramanPrasanth GanesanTrivadi S GanesanManikandan DhanushkodiTenali G Sagar

Published in: Pediatric blood & cancer (2018)

Addition of fosaprepitant to ondansetron and dexamethasone improved chemotherapy-induced vomiting control in children treated with moderately or highly emetogenic chemotherapy.

Keyphrases

chemotherapy induced
phase iii
placebo controlled
double blind
young adults
open label
clinical trial
high dose
phase ii
low dose
study protocol
randomized controlled trial